UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report
(Date of Earliest Event Reported): Commission File Number:
July 23, 2007 0-17449
PROCYON CORPORATION
-------------------
(Exact name of Registrant as specified in its charter)
Colorado 59-3280822
-------- ----------
(State of incorporation) (I.R.S. Employer Identification Number)
1300 S. HIGHLAND
CLEARWATER, FL 33756
(727) 447-2998
(Address of principal executive offices
and telephone number)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
Item 8.01 Other Events.
On July 23, 2007, Procyon Corporation (the "Company") issued a press
release announcing that the Company's wholly-owned subsidiary, Amerx HealthCare
Corporation, recently received a Federal Supply Schedule number from the
Government Services Administration. A copy of this press release is attached
hereto as Exhibit 99.1 and the information contained therein is incorporated
herein by reference.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits.
Exhibit No. Description
----------- -----------
99.1 Press release dated July 23, 2007.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Date: July 23, 2007 Procyon Corporation
By: /s/ Regina W. Anderson
--------------------------
Regina W. Anderson,
Chief Executive Officer